WirostkoB., MannB., and StirlandD.Letter to the Editor Re: Cross-Linked Hyaluronic Acid as Tear Film Substitute. J. Ocul. Pharm. Ther. 36:205, 2020.
2.
WilliamsD.L., WirostkoB.M., GumG., and MannB.Topical crosslinked HA-based hydrogel accelerates closure of corneal epithelial defects and repair of stromal ulceration in companion animals. Invest. Ophthalmol. Vis. Sci. 58:4616–4622, 2017.
3.
DurrieD.S., WolseyD., ThompsonV., AssangC., MannB., and WirostkoB.Accelerating re-epithelialization after photorefractive keratectomy with an ocular bandage gel. J. Cataract. Refract. Surg. 44:369–375, 2018.
4.
PosarelliC., PassaniA., Del ReM., FogliS., ToroM.D., FerrerasA., and FigusM.Cross-linked hyaluronic acid as a tear film substitute. J. Ocul. Pharmacol. Ther. 35:381–387, 2019.
5.
InoueM., and KatakamiC.The effect of hyaluronic acid on corneal epithelial cell proliferation. Invest. Ophthalmol. Vis. Sci. 34:2313–2315, 1993.
6.
GomesJ.A.P., AmankwahR., Powell-RichardsA., and DuaH.S.Sodium hyaluronate (hyaluronic acid) promotes migration of human corneal epithelial cells in vitro. Br. J. Ophthalmol. 88:821–825, 2004.
7.
KimY.H., KangY.S., LeeH.S., ChoiW., YouI.C., and YoonK.C.Effectiveness of combined tear film therapy in patients with evaporative dry eye with short tear film breakup time. J. Ocul. Pharmacol. Ther. 33:635–643, 2017.
